These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 35127635)

  • 21. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of COVID-19 on Urban Population Flow in China.
    Jiang X; Wei W; Wang S; Zhang T; Lu C
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China during and after the epidemic peak in China.
    Costantino V; Heslop DJ; MacIntyre CR
    J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32453411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research on the influence of the COVID-19 epidemic on work stress of returning workers in China: A study based on empirical analyses of industrial enterprises.
    Yang Q; Huo J; Li J; Jiang Y
    Work; 2020; 67(1):67-79. PubMed ID: 32955475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety considerations during return to work in the context of stable COVID-19 epidemic control: an analysis of health screening results of all returned staff from a hospital.
    Duan P; Deng ZQ; Pan ZY; Wang YP
    Epidemiol Infect; 2020 Sep; 148():e214. PubMed ID: 32943130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing and Predicting Green Credit Risk in the Paper Industry.
    Zhao Y; Chen Y
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36430092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Discussion on early warning, prevention and control of emerging infectious diseases from a macroscopic perspective based on big data and effective distance model: enlightenment of COVID-19 epidemic data in China].
    Wang ZK; Chen ZS; Du AH; Wang CY; Liu H; Wang ZW; Hu JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):1989-1993. PubMed ID: 32340090
    [No Abstract]   [Full Text] [Related]  

  • 29. The COVID-19 epidemic and other notifiable infectious diseases in China.
    Bai BK; Jiang QY; Hou J
    Microbes Infect; 2022 Feb; 24(1):104881. PubMed ID: 34419605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gravitational scaling analysis on spatial diffusion of COVID-19 in Hubei Province, China.
    Chen Y; Li Y; Feng S; Man X; Long Y
    PLoS One; 2021; 16(6):e0252889. PubMed ID: 34115791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real Workload-Situated Training in COVID-19 Prevention of General Practice Residents in China: A Situated Cognition Study.
    Xin R; Li L; Qiaoli S; Xingyue W
    Front Public Health; 2021; 9():765402. PubMed ID: 34869179
    [No Abstract]   [Full Text] [Related]  

  • 32. Health systems preparedness during COVID-19 pandemic: China and India.
    Baru RV
    Indian J Public Health; 2020 Jun; 64(Supplement):S96-S98. PubMed ID: 32496234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 34. Health Shocks and Unbalanced Growth of Medical Resources: Evidence From the SARS Epidemic in China.
    Wang J; Wu H
    Int J Health Serv; 2022 Jan; 52(1):47-60. PubMed ID: 33423602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The COVID-19-designated hospitals in China: preparing for public health emergencies.
    Li Q; Wang L; Wang B; Lu H
    Emerg Microbes Infect; 2021 Dec; 10(1):998-1001. PubMed ID: 33993856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Questionnaire Survey on the Current Situation and Experience in Prevention and Control Measures at Urology Clinics During the COVID-19 Epidemic in China.
    Zhu XL; Jiang HH; Jiang MH; Liu WL; Sheng ZL; Liu JH; Wang M
    Front Public Health; 2021; 9():670889. PubMed ID: 34490178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors of Psychological Responses of Chinese University Students During the COVID-19 Outbreak: Cross-sectional Web-Based Survey Study.
    Zhang X; Shi X; Wang Y; Jing H; Zhai Q; Li K; Zhao D; Zhong S; Song Y; Zhang F; Bao Y
    J Med Internet Res; 2021 Jul; 23(7):e29312. PubMed ID: 34156961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic.
    Ping W; Zheng J; Niu X; Guo C; Zhang J; Yang H; Shi Y
    PLoS One; 2020; 15(6):e0234850. PubMed ID: 32555642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How Is the Risk of Major Sudden Infectious Epidemic Transmitted? A Grounded Theory Analysis Based on COVID-19 in China.
    Duan X; Zhang Z; Zhang W
    Front Public Health; 2021; 9():795481. PubMed ID: 34900927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and Predictors of PTSD During the Initial Stage of COVID-19 Epidemic among Female College Students in China.
    Si MY; Su XY; Jiang Y; Wang WJ; Gu XF; Ma L; Li J; Zhang SK; Ren ZF; Liu YL; Qiao YL
    Inquiry; 2021; 58():469580211059953. PubMed ID: 34933595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.